ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin- Free Method] Post-Authorization Safety Surveillance (PASS): Safety and Efficacy Following Product Switch in Routine Clinical Practice.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2008 112(11):3375-3375 - Subject
- Language
- ISSN
- 0006-4971